175 related articles for article (PubMed ID: 31143183)
21. T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis.
Salajegheh M; Rakocevic G; Raju R; Shatunov A; Goldfarb LG; Dalakas MC
Neurology; 2007 Oct; 69(17):1672-9. PubMed ID: 17954782
[TBL] [Abstract][Full Text] [Related]
22. Extracellular hemoglobin polarizes the macrophage proteome toward Hb-clearance, enhanced antioxidant capacity and suppressed HLA class 2 expression.
Kaempfer T; Duerst E; Gehrig P; Roschitzki B; Rutishauser D; Grossmann J; Schoedon G; Vallelian F; Schaer DJ
J Proteome Res; 2011 May; 10(5):2397-408. PubMed ID: 21405025
[TBL] [Abstract][Full Text] [Related]
23. The role of interferons type I, II and III in myositis: A review.
Bolko L; Jiang W; Tawara N; Landon-Cardinal O; Anquetil C; Benveniste O; Allenbach Y
Brain Pathol; 2021 May; 31(3):e12955. PubMed ID: 34043262
[TBL] [Abstract][Full Text] [Related]
24. Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments.
Fonseca JE; Edwards JC; Blades S; Goulding NJ
Arthritis Rheum; 2002 May; 46(5):1210-6. PubMed ID: 12115225
[TBL] [Abstract][Full Text] [Related]
25. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma.
Shiraishi D; Fujiwara Y; Horlad H; Saito Y; Iriki T; Tsuboki J; Cheng P; Nakagata N; Mizuta H; Bekki H; Nakashima Y; Oda Y; Takeya M; Komohara Y
Cancer Res; 2018 Jun; 78(12):3255-3266. PubMed ID: 29610117
[TBL] [Abstract][Full Text] [Related]
26. Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells.
Martín-Ventura JL; Madrigal-Matute J; Muñoz-Garcia B; Blanco-Colio LM; Van Oostrom M; Zalba G; Fortuño A; Gomez-Guerrero C; Ortega L; Ortiz A; Diez J; Egido J
Cardiovasc Res; 2009 Aug; 83(3):586-94. PubMed ID: 19423618
[TBL] [Abstract][Full Text] [Related]
27. The macrophage scavenger receptor CD163.
Fabriek BO; Dijkstra CD; van den Berg TK
Immunobiology; 2005; 210(2-4):153-60. PubMed ID: 16164022
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas.
Lin MW; Yang CY; Kuo SW; Wu CT; Chang YL; Yang PC
Ann Surg Oncol; 2016 Sep; 23(9):3071-81. PubMed ID: 27150441
[TBL] [Abstract][Full Text] [Related]
29. Targetted inhibition of CD74 attenuates adipose COX-2-MIF-mediated M1 macrophage polarization and retards obesity-related adipose tissue inflammation and insulin resistance.
Chan PC; Wu TN; Chen YC; Lu CH; Wabitsch M; Tian YF; Hsieh PS
Clin Sci (Lond); 2018 Jul; 132(14):1581-1596. PubMed ID: 29773671
[TBL] [Abstract][Full Text] [Related]
30. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
[TBL] [Abstract][Full Text] [Related]
31. The ratio of CD163-positive macrophages to Iba1-positive macrophages is low in the intima in the early stage of cutaneous arteritis.
Kobayashi M; Matsumoto Y; Satomi H; Tateishi A; Ohya M; Ito I; Kanno H
Immunol Res; 2020 Jun; 68(3):152-160. PubMed ID: 32578130
[TBL] [Abstract][Full Text] [Related]
32. Diversity in phenotype and steroid hormone dependence in dendritic cells and macrophages in the mouse uterus.
Keenihan SN; Robertson SA
Biol Reprod; 2004 Jun; 70(6):1562-72. PubMed ID: 14766730
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory myopathy with abundant macrophages (IMAM): the immunology revisited.
Rinnenthal JL; Goebel HH; Preuße C; Lebenheim L; Schumann M; Moos V; Schneider T; Heppner FL; Stenzel W
Neuromuscul Disord; 2014 Feb; 24(2):151-5. PubMed ID: 24314585
[TBL] [Abstract][Full Text] [Related]
34. The significance of CD163-expressing macrophages in asthma.
Tokunaga Y; Imaoka H; Kaku Y; Kawayama T; Hoshino T
Ann Allergy Asthma Immunol; 2019 Sep; 123(3):263-270. PubMed ID: 31152786
[TBL] [Abstract][Full Text] [Related]
35. Classically or alternatively activated bovine monocyte-derived macrophages in vitro do not resemble CD163/Calprotectin biased macrophage populations in the teat.
Düvel A; Frank C; Schnapper A; Schuberth HJ; Sipka A
Innate Immun; 2012 Dec; 18(6):886-96. PubMed ID: 22627785
[TBL] [Abstract][Full Text] [Related]
36. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
Pinkus JL; Amato AA; Taylor JP; Greenberg SA
Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
[TBL] [Abstract][Full Text] [Related]
37. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis.
Tateyama M; Fujihara K; Misu T; Itoyama Y
J Neurol Sci; 2009 Apr; 279(1-2):47-52. PubMed ID: 19171354
[TBL] [Abstract][Full Text] [Related]
38. A subset of CD163+ macrophages displays mixed polarizations in discoid lupus skin.
Chong BF; Tseng LC; Hosler GA; Teske NM; Zhang S; Karp DR; Olsen NJ; Mohan C
Arthritis Res Ther; 2015 Nov; 17():324. PubMed ID: 26568320
[TBL] [Abstract][Full Text] [Related]
39. Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer.
Greenwood C; Metodieva G; Al-Janabi K; Lausen B; Alldridge L; Leng L; Bucala R; Fernandez N; Metodiev MV
J Proteomics; 2012 Jun; 75(10):3031-40. PubMed ID: 22178447
[TBL] [Abstract][Full Text] [Related]
40. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells.
Dalakas MC; Rakocevic G; Shatunov A; Goldfarb L; Raju R; Salajegheh M
Ann Neurol; 2007 May; 61(5):466-75. PubMed ID: 17366634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
